Document is current
Any future updates will be listed below
-
Authors
Singh, Shalini https://orcid.org/0000-0001-5564-3466
Islam, S. M. Shamsul
Liu, Rui
Adeniji, Opeyemi S.
Simons, Lacy M. https://orcid.org/0000-0003-4041-6775
Saini, Pratima
Tateno, Hiroaki https://orcid.org/0000-0003-3006-1659
Danesh, Ali
Denton, Paul W. https://orcid.org/0000-0003-2458-8147
Giron, Leila B.
Jones, R. Brad https://orcid.org/0000-0003-4470-1231
Hultquist, Judd F. https://orcid.org/0000-0001-6424-4280
Xiao, Han
Abdel-Mohsen, Mohamed https://orcid.org/0000-0002-9945-4314
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI165079)
- License Information
-
More Information
Article History
Received: 7 February 2025
Accepted: 10 November 2025
First Online: 13 December 2025
Competing interests
: J.F.H. received research support, paid to Northwestern University, from Gilead Sciences and is a paid consultant for Merck and Ridgeback Biotherapeutics. All other authors declare no competing interests.
